Mencouccal Meningitis Research Paper

Meningitis started in 1805,in Switzerland. There were numerous outbreaks,later showing up in the U.S the following year.In 1887,Anton Weichselbaum discovered and proved that bacteria is another way that can cause meningitis.20 years later,SimonFlexner created a medicine made up of horse blood.Later a more helpful antibotiacs was found in the late mid-1940’s by a group of doctors called pennicillin ,which is a

It is said that the symptoms for each type of meningitis are similar, but there is differences for each. The severity and treatments of the disease basically lets doctors know what medication

Meningitis can be destructive without proper understanding of what it is caused by. There are three types of meningitis- bacterial, fungal, and viral. Contrasting factors tend to arise during a comparison of them. One of the most notable areas that viral, fungal and bacterial meningitis differ in are their treatment ability. However, they have the same general affects on the human body. In any case, there are tests that doctors can utilize in order to discover if the meningitis is bacterial, fungal, or viral.

In fact, a specific region of Africa has been dubbed the meningitis belt. Those living in this sub-Saharan region stretching from Senegal to Gambia are at risk for the lethal epidemics that ravage the land during most dry seasons ("PATH."). Bacterial meningitis works in a very specific way, with quite a few symptoms; however, adequate treatments and vaccines have been developed.

Africa has the highest incidence of meningococcal disease, tuberculosis, and malaria because of overcrowding in many villages. There is an area in sub-Saharan Africa called the Meningitis Belt that stretches from Senegal to Ethiopia with over 20,000 reported cases and 2,000 deaths every year (Healthgrades editorial staff, 2015). During the dry season in Africa, from December through June, meningitis epidemics occur with the three major areas infected being Burkina Faso, Nigeria, and Chad. The most recent outbreak of the meningococcal disease reported in the United States occurred as meningitis in the dorms at the University of California, Santa Barbara and Princeton University in New Jersey in December of 2013 (Doheny, 2013). When the outbreak occurred at these two universities it was caused from serotype B of the disease and resulted in one death. Since the current meningococcal vaccine does not cover the serotype B bacteria the FDA allowed the use of a special vaccine from New Zealand to treat the outbreaks (Burrell, 2015). One in five US teens have not had their first recommended dose of meningococcal vaccine and for those who have had the first dose of the vaccine,

Meningitis, also known as spinal meningitis, is a viral or bacterial infection causing inflammation of the membranes, called meninges. Meninges act as a natural protective barrier that surrounds the brain and spinal cord. When the barrier is permeable, infections are able to transmit a disease in or through and cause serious or even fatal effects. There are different causes for the different categories of meningitis resulting in different symptoms and severities in each.

In nineteenth century Geneva, a family came down with a strange disease— one that had never previously been diagnosed. In a short time, many people in their town were infected and thirty-three people were left dead. This strange disease was later determined to be meningitis. In 1806, the United States saw its first outbreak of meningitis in Massachusetts. It was not until 1887, however, that Professor Anton Weichselbaum was able to determine a cause of meningitis: a bacterium called Neisseria meningitides. Penicillin was first used to combat meningitis in 1944, and in 1978, a vaccine became available. The usage of vaccines was detrimental in the battle to gain control over the spread of meningitis (7). Even with these vaccines, however,

     3,000 Americans contract Bacterial Meningitis each year. Out of those 3,000, about 10 %, or 300 people, die from the infection. Approximately 125 of these cases occur on college campuses across the country. Out of these campus outbreaks, there is an annual average of 10 student deaths.

And for those who are still afraid of vaccinated, the CDC, Food and Drug Administration (FDA), Institute of Medicine (IOM), American Medical Association (AMA), American Academy of Pediatrics (AAP), UNICEF, US Department of Health and Human Services (HHS), World Health Organization (WHO), Public Health Agency of Canada, Canadian Paediatric Society, National Foundation for Infectious Diseases (NFID), and the American Academy of Family Physicians (AAFP) have all approved the current meningitis vaccine. This is why I urge you, fellow representatives, to vote with me in affirmation of the

     In 1887, the causative agent Neisseria Meningitidis, the meningococcus, was identified. Because of its potential to cause epidemics, Neisseria Meningitidis is one of the most important types. In 1805, when Meningococcal disease was first described, an outbreak swept through Geneva, Switzerland. Twelve subtypes of Neisseria Meningitidis have been identified. Four of them have been recognized to cause epidemics. Those four are: A, B, C, and W135. The capabilities differ of the pathogenicity, immunogenicity, and

It is the one the biggest challenges a child is taking on in their young adult life. They just graduated high school, and now they are moving into a college dormitory. They are taking a big step in their life; working for a bachelor’s degree in their highest interest. The doctor and the university is persistent in making sure the child has all their vaccinations. One major vaccination is the Meningococcal Meningitis shot. Meningitis takes a major toll on young adults, especially in the college setting. The last thing anyone wants to hear, is their child has died from Meningitis. Especially when there is a simple vaccination the child can obtained. Not to mention most universities, if not all, require the vaccine. Meningitis has

in countries throughout the meningitis belt of Africa due to the emergence of a new serogroup. The best way to avoid epidemics are to establish surveillance and early detection, followed by mass emergency vaccination campaigns. Surveillance is conducted worldwide through International Disease Notification. Also in the United States by NETSS, and NCID Emerging Infection Program's Active Bacterial Core surveillance (ABCs). (CDC, 2004)

N. meningitides bacterium responsible for outbreaks in densely populated areas such as childcare centers, boarding schools, or college living areas (Smeltzer, Bare, Hinkle, & Cheever, 2010). These outbreaks are most common in winter and spring months when risk factors like upper respiratory infections are more likely (Smeltzer, Bare, Hinkle, & Cheever, 2010). Immunosuppression must be present for this pathogen to invade. Other risk factors for meningitis are otitis media (middle ear infection), mastoiditis (mastoid bone infection) (Smeltzer, Bare, Hinkle, & Cheever, 2010), systemic sepsis, sinusitis (sinus infection), basilar skull fractures, and the very young and the very old (Porth & Matfin, 2009).

In 1906 it was first discovered that horses were a viable source to make antibodies that could be used against the meningococcal bacteria. This was then further looked into and made more progress by an American scientist by the name of Simon Flexner. Flexner’s further development of the antibodies from the horses aided in the attempt to lower the mortality rate from the meningococcal disease. (1) The first reported case of using penicillin against meningitis and effectively working was not until over forty years later. Georg Joachmann, in Germany, and Flexner, in America, were the firsts to successfully treat meningitis with introduction of the serum therapy for meningococcal meningitis.

Meningococcal disease is a large concern in the medical field because it is unbiased towards the patients it infects. There has been limited success in trying to eliminate this disease. Antibiotics play a role in helping to treat patients with bacterial meningitis, and steroids have been tested to help reduce risk factors. Prevention has also become a key issue because meningitis can only be spread through direct contact with infected body fluid. The best prevention is to maintain clean hygiene. Vaccines are another way of preventing disease. However, there are multiple serogroups of meningitis that makes creating a universal vaccine extremely difficult. So far, there have only been two